Analysis of KRAS, NRAS, BRAF and PIK3CA Mutations in Matched Primary and Metastatic Colorectal Carcinomas

被引：0
|
作者：
Vakiani, E. [1 ]
Janackinaram, M. [1 ]
Shia, J. [1 ]
Saltz, L. [1 ]
Kemeny, N. [1 ]
Weiser, M. [1 ]
Solit, D. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
LABORATORY INVESTIGATION | 2011年 / 91卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
716
引用
收藏
页码：171A / 171A
页数：1
相关论文
共 50 条
  • [1] Analysis of KRAS, NRAS, BRAF and PIK3CA Mutations in Matched Primary and Metastatic Colorectal Carcinomas
    Vakiani, E.
    Janackinaram, M.
    Shia, J.
    Saltz, L.
    Kemeny, N.
    Weiser, M.
    Solit, D.
    MODERN PATHOLOGY, 2011, 24 : 171A - 171A
  • [2] Prognostic impact of KRAS, NRAS, BRAF, and PIK3CA mutations in primary colorectal carcinomas: a population-based study
    Grazia Palomba
    Valentina Doneddu
    Antonio Cossu
    Panagiotis Paliogiannis
    Antonella Manca
    Milena Casula
    Maria Colombino
    Annamaria Lanzillo
    Efisio Defraia
    Antonio Pazzola
    Giovanni Sanna
    Carlo Putzu
    Salvatore Ortu
    Mario Scartozzi
    Maria Teresa Ionta
    Giovanni Baldino
    Giuseppina Sarobba
    Francesca Capelli
    Tito Sedda
    Luciano Virdis
    Michela Barca
    Giulia Gramignano
    Mario Budroni
    Francesco Tanda
    Giuseppe Palmieri
    Journal of Translational Medicine, 14
  • [3] Prognostic impact of KRAS, NRAS, BRAF, and PIK3CA mutations in primary colorectal carcinomas: a population-based study
    Palomba, Grazia
    Doneddu, Valentina
    Cossu, Antonio
    Paliogiannis, Panagiotis
    Manca, Antonella
    Casula, Milena
    Colombino, Maria
    Lanzillo, Annamaria
    Defraia, Efisio
    Pazzola, Antonio
    Sanna, Giovanni
    Putzu, Carlo
    Ortu, Salvatore
    Scartozzi, Mario
    Ionta, Maria Teresa
    Baldino, Giovanni
    Sarobba, Giuseppina
    Capelli, Francesca
    Sedda, Tito
    Virdis, Luciano
    Barca, Michela
    Gramignano, Giulia
    Budroni, Mario
    Tanda, Francesco
    Palmieri, Giuseppe
    JOURNAL OF TRANSLATIONAL MEDICINE, 2016, 14
  • [4] Prognostic role of KRAS, NRAS, BRAF and PIK3CA mutations in advanced colorectal cancer
    Foltran, Luisa
    De Maglio, Giovanna
    Pella, Nicoletta
    Ermacora, Paola
    Aprile, Giuseppe
    Masiero, Elena
    Giovannoni, Mariella
    Iaiza, Emiliana
    Cardellino, Giovanni Gerardo
    Lutrino, Stefania Eufemia
    Mazzer, Micol
    Giangreco, Manuela
    Pisa, Federica Edith
    Pizzolitto, Stefano
    Fasola, Gianpiero
    FUTURE ONCOLOGY, 2015, 11 (04) : 629 - 640
  • [5] The role of KRAS, BRAF, NRAS, and PIK3CA mutations as markers of resistance to cetuximab in chemorefractory metastatic colorectal cancer
    Lambrechts, D.
    De Roock, W.
    Prenen, H.
    De Schutter, J.
    Jacobs, B.
    Biesmans, B.
    Claes, B.
    De Hertogh, G.
    Van Cutsem, E.
    Tejpar, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [6] Elucidating the prognostic significance of KRAS, NRAS, BRAF and PIK3CA mutations in Chinese patients with metastatic colorectal cancer
    Ma, Brigette B.
    Mo, Frankie
    Tong, Joanna H.
    Wong, Ashley
    Wong, S. C. Cesar
    Ho, Wing M.
    Wu, Cherry
    Lam, Polly W. Y.
    Chan, K. F.
    Chan, Timothy S. K.
    Tsui, Wilson M. S.
    Tsang, Alex K. H.
    Fung, Mandy N. S.
    Chan, Anthony T. C.
    To, Ka Fai
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2015, 11 (02) : 160 - 169
  • [7] Comparison of three molecular methods to detect mutations in KRAS, NRAS, BRAF and PIK3CA in metastatic colorectal cancer (mCRC).
    Santos, Cristina
    Garcia-Carbonero, Rocio
    Alfonso, Pilar Garcia
    Azuara, Daniel
    Varela, Mar
    Navarro-Perez, Valentin
    Carrato, Alfredo
    Elez, Elena
    Gomez-Espana, M. Auxiliadora
    Losa, Ferran
    Montagut, Clara
    Massuti, Bartomeu
    Manzano, Jose Luis
    Vieitez, Jose M.
    Valladares, Manuel
    Sanjuan, Xavier
    Capella, Gabriel
    Aranda, Enrique
    Tabernero, Josep
    Salazar, Ramon
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [8] Analysis of KRAS, NRAS, BRAF, and PIK3CA mutations could predict metastases in colorectal cancer: A preliminary study
    Wojas-Krawczyk, Kamila
    Kalinka-Warzocha, Ewa
    Reszka, Katarzyna
    Nicos, Marcin
    Szumilo, Justyna
    Mandziuk, Slawomir
    Szczepaniak, Katarzyna
    Kupnicka, Dorota
    Lewandowski, Remigiusz
    Milanowski, Janusz
    Krawczyk, Pawel
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 28 (01): : 67 - 73
  • [9] Concordant analysis of KRAS, BRAF, PIK3CA mutations and PTEN expression between primary colorectal cancer and matched metastases
    Chen Mao
    Xin-Yin Wu
    Zu-Yao Yang
    Diane Erin Threapleton
    Jin-Qiu Yuan
    Yuan-Yuan Yu
    Jin-Ling Tang
    Scientific Reports, 5
  • [10] Concordant analysis of KRAS, BRAF, PIK3CA mutations, and PTEN expression between primary colorectal cancer and matched metastases
    Mao, Chen
    Wu, Xin-Yin
    Yang, Zu-Yao
    Threapleton, Diane Erin
    Yuan, Jin-Qiu
    Yu, Yuan-Yuan
    Tang, Jin-Ling
    SCIENTIFIC REPORTS, 2015, 5 : 8065
12345